Resultados de la búsqueda 121-130 of 12270 for Relaxin-2

  1. Medicina de emergencia - Ensayos clínicos - Mayo Clinic

    CVC placement will use the low-fidelity simulator (Gen II Ultrasound Central Line Training Model, CAE Healthcare). All placements will be video recorded. A ...

  2. Untitled

    Page 1. Page 2. Page 3. Page 4.

  3. Oncología (médica) - Ensayos clínicos

    ... 2 genes (BRCA 1/2) and PALB2 associated HER2-negative metastatic breast cancer. The names of the study drugs involved in this study are: * Axatilimab (a ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

  5. Medicina Interna Hospitalaria - Ensayos clínicos - Mayo Clinic

    In addition to Tier 1 procedures, at each in-person follow-up visit: Tier 2 participants will also undergo MRI scanning, comprehensive cognitive assessment ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... 2 genes (BRCA 1/2) and PALB2 associated HER2-negative metastatic breast cancer. The names of the study drugs involved in this study are: * Axatilimab (a ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... 2 genes (BRCA 1/2) and PALB2 associated HER2-negative metastatic breast cancer. The names of the study drugs involved in this study are: * Axatilimab (a ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... 2 genes (BRCA 1/2) and PALB2 associated HER2-negative metastatic breast cancer. The names of the study drugs involved in this study are: * Axatilimab (a ...

  10. Neurología - Ensayos clínicos - Mayo Clinic

    ... 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated ... (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype ...